Genetics of gout
PT-141 moves through the body as an antagonist to melanocortin receptors
Compared with nonusers, adults taking GLP-1s had a: 17 percent lower risk of venous thromboembolism, or blood clots in the veins 31 percent lower risk of pulmonary embolism, a potentially life-threatening clot that travels to the lungs 21 percent lower risk of going to the emergency department 44 percent lower risk of all-cause mortality (death from any cause) Researchers also observed lower stroke rates among GLP-1 users, although this difference didnt reach statistical significance
Substance Use & Misuse, 45(14), 2428-2443
In part, this risk relates back to one of the main benefits of GLP-1s: rapid weight loss
Ghanei E, Baghani M, Moravvej H, Talebi A, Abdollahimajd F